At Novo Nordisk, we are driving change to defeat diabetes and other serious chronic diseases.
Novo Nordisk is a global healthcare company with more than 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic diseases: haemophilia, growth disorders and obesity.
Headquartered in Denmark, Novo Nordisk employs approximately 43,200 people in 80 countries and markets its products in more than 170 countries.
Our company culture
The Novo Nordisk Way – who we are, where we want to go and how we work
Each and every employee is responsible for acting in accordance with the Novo Nordisk Way – and to help each other understand what it means in practice.
Our business philosophy
The Triple Bottom Line – our way of doing business
We have built our business on the conviction that the formula for lasting success is to stay focused, think long-term and do business in a financially, socially and environmentally responsible way. That is why we manage our business in accordance with the Triple Bottom Line principle.
Changing the world of diabetes for more than 90 years
Behind the Novo Nordisk we know today lies an exciting story that goes back more than 90 years. It began with the two small Danish companies Nordisk Insulinlaboratorium and Novo Terapeutisk Laboratorium founded in 1923 and 1925, respectively. The two companies started the production of the revolutionary new drug insulin that had just been discovered by two Canadian scientists.
Building on the past – looking to the future
Since the earliest days, both Nordisk and Novo had focus on the development of products to benefit people with diabetes. Competing intensely with one another, the companies developed into two of the best in their field. When at last they decided to merge in 1989, they created Novo Nordisk. A company that has been expanding rapidly ever since with leading positions within diabetes care, obesity care, haemophilia care, growth hormone therapy and hormone replacement therapy.
Today the Novo Nordisk Way shows responsibility to patients, employees, communities and investors. We will in the future continue to build on the legacy left by the founders of Novo Nordisk and do whatever it takes to change diabetes. Our history tells us it can be done.